Clinical Study Site

New York, New York 10075

4 studies enrolling now · 8 studies all time

What they study most

C3 Glomerulonephritis, C3 Glomerulopathy, Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Stable Plaque Psoriasis, Colitis, Ulcerative, Dense Deposit Disease, Fabry Disease, Inflammatory Bowel Diseases, Locally Advanced / Metastatic Solid Tumors, Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer

Studies at this site

• Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer — Recruiting now
• CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors — Recruiting now
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 — Recruiting now
• A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) — Recruiting now
• A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC — Completed
• A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G) — Completed
• Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease — Completed
• Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis — Completed